Conclave - 2024 champions global supply chain resilience and quality excellence through collaborations: Shardul Nautiyal, ...
Kiran Mazumdar-Shaw honoured by ISQ with ‘Jamsetji Tata Award’ for pioneering biosciences movement in India: Our Bureau, ...
US FDA approves Neurocrine Biosciences’ Crenessity to treat children and adults with classic congenital adrenal hyperplasia: San Diego Monday, December 16, 2024, 16:00 Hrs [IST] ...
Lupin Digital Health partners with Medicover Hospitals for comprehensive post-discharge cardiac care: Our Bureau, Mumbai Monday, December 16, 2024, 15:45 Hrs [IST] Lupin Digital H ...
US FDA clears Zimmer Biomet’s OsseoFit Stemless Shoulder System for total shoulder replacement: Warsaw, Indiana Monday, December 16, 2024, 15:00 Hrs [IST] Zimmer Biomet Holdings ...
EMA’s CHMP committee recommends approval of Biocon Biologics’ Yesintek: Our Bureau, Bengaluru Monday, December 16, 2024, 14:30 Hrs [IST] Biocon Biologics (BBL), a fully integr ...
Ayurveda app developed by Kerala Ayurveda doctors attracted visitors at the WAC Arogya Expo: Our Bureau, Mumbai Monday, December 16, 2024, 14:15 Hrs [IST] A comprehensive clinical ...
Having recently signed an agreement to fight rabies in Kenya, particularly Machakos County, Boehringer Ingelheim and Vétérinaires sans Frontières Germany (VSF Germany) continue their successful ...
EMA’s human medicine committee recommends marketing approval for acoramidis for treatment of transthyretin amyloid cardiomyopathy: Berlin Monday, December 16, 2024, 13:00 Hrs [I ...
Sanofi’s tolebrutinib to treat non-relapsing secondary progressive multiple sclerosis receives US FDA breakthrough therapy designation: Paris Monday, December 16, 2024, 12:00 Hr ...
Glenmark Pharma launches lacosamide oral solution, 10 mg/mL in US markets: Our Bureau, Mumbai Monday, December 16, 2024, 12:45 Hrs [IST] Glenmark Pharmaceuticals Inc., USA (Glenma ...
CPHI Milan – the world’s largest pharma event – hosted last month in Milan saw a new record attendance of 59,000 pharma executives buoyed by returning confidence and increased dealmaking on site. The ...